Toggle light / dark theme

Comparative analysis of genome code complexity and manufacturability with engineering benchmarks

When knowledge has advanced to a state that includes a predictive understanding of the relationship between genome sequence and organism phenotype it will be possible for future engineers to design and produce synthetic organisms. However, the possibility of synthetic biology does not necessarily guarantee its feasibility, in much the same way that the possibility of a brute force attack fails to ensure the timely breaking of robust encryption. The size and range of natural genomes, from a few million base pairs for bacteria to over 100 billion base pairs for some plants, suggests it is necessary to evaluate the practical limits of designing genomes of similar complexity.

Bill Andrews deep research to cure aging explained in 19 minutes (con S/T en Español)

In this video Bill Andrews summarizes in 19 minutes his extensive research on telomeres, aging, and his proposal to cure aging. Bill Andrews is an American molecular biologist and gerontologist, founder and CEO of the biotech company Sierra Sciences.


Bill Andrews summarizes in 19 minutes his extensive and prolific research on telomeres, aging, and the cure for aging.

The video, originally released by Bill Andrews in february 2022, among other things, covers in little less than 20 minutes the following:

1) Enlightening info about telomere shortening and its impact on aging.

2) Practical proposals to cure aging based on two different approaches to stop telomere shortening and actually enlarge them.

New Brain Map Charts Every Component in the Biological Universe

It’s easy to see why: as shockingly powerful mini-processors, neurons and their connections—together dubbed the connectome—hold the secret to highly efficient and flexible computation. Nestled inside the brain’s wiring diagrams are the keys to consciousness, memories, and emotion. To connectomics, mapping the brain isn’t just an academic exercise to better understand ourselves—it could lead to more efficient AI that thinks like us.

But often ignored are the brain’s supporting characters: astrocytes—brain cells shaped like stars—and microglia, specialized immune cells. Previously considered “wallflowers,” these cells nurture neurons and fine-tune their connections, ultimately shaping the connectome. Without this long-forgotten half, the brain wouldn’t be the computing wizard we strive to imitate with machines.

In a stunning new brain map published in Cell, these cells are finally having their time in the spotlight. Led by Dr. H. Sebastian Seung at Princeton University, the original prophet of the connectome, the map captures a tiny chunk of the mouse’s visual cortex, less than 1,000 times smaller than a pea. Yet jam-packed inside the map aren’t just neurons; in a technical tour de force, the team mapped all brain cells, their connections, blood vessels, and even the compartments inside cells that house DNA and produce energy.

What might explain Huntington’s Disease?

Could 2 B vitamins help those suffering with Huntington’s Disease?


T he Huntington’s disease (HD) community has recently experienced setbacks, but a new research report may reignite hope, from an unexpected source: the vitamin thiamine (B1), with help from biotin (B7). The investigators, from several institutions in Spain and UCLA, write in Science Translational Medicine, “Together, these results demonstrate a thiamine deficiency in HD brain and suggest that individuals with HD might benefit from thiamine and/or biotin supplementation therapy.”

Health care providers may suggest certain supplements for HD patients, based perhaps on a deficiency (vitamins C, B12, E) in the blood, or for general health. But the new findings are different. The researchers didn’t set out to detect a vitamin deficiency, but instead probed the messaging within cells in the HD brain, which led them to a biochemical juncture that revealed the thiamine/biotin connection.

Peter Diamandis Describes How Applying AI to Drug Discovery is Causing Positive Disruption to Biopharma

The content of Peter’s email blast has been edited by me (can’t help myself). But I believe I have captured its essence and hope you enjoy the retelling. As always your comments are welcomed.

What is Insilico Medicine?

Insilico Medicine is a pioneering drug company that is powered by a “drug discovery engine” that sifts through millions of data samples to determine the signature biological characteristics of specific diseases. It then identifies the most promising treatment targets and uses a new AI technique called generative adversarial networks (GANs) to create molecules perfectly suited against them.

The 3G shutdown will affect everyday devices you probably own

The looming shutdown of 3G networks won’t just impact older phones.

With AT&T’s 3G network shutting down next week, and other carriers following suit later this year, a range of products require updates to continue working, including some home alarm systems, medical devices such as fall detectors, and in-car crash notification and roadside assistance systems such as General Motors’ OnStar.

Just as many mobile carriers have urged customers to swap their older 3G iPhones, Android phones, e-readers and other handheld devices for newer models ahead of the shutdown, other businesses are urging customers to upgrade or replace some of the everyday products and services in their homes and cars before they drop connectivity.

Progress, Potential, and Possibilities

Progress, Potential, And Possibilities has had another busy month! — Come subscribe & enjoy all of our fascinating guest who are creating a better tomorrow! #Health #Longevity #Biotech #Space #AI #Technology #Medicine #Entertainment #Energy #Regeneration #Environment #Sustainability #Food #Innovation #Future #Defense #STEM #Aging #IraPastor


Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us — Host — Ira S. Pastor.

Hypertonic saline solution with furosemide infusion may be beneficial in fluid overload in patients with reduced ejection fraction

Background: Diuretic-resistant fluid overload is a common problem encountered in hospitalized heart failure (HF) patients, with different interventions proposed to overcome it. Some studies have suggested that combining hypertonic saline with furosemide provided advantages over furosemide alone.

Study design: Systematic review and meta-analysis.

Setting: A comprehensive search of several databases from each database’s inception to March 17, 2020, and reference lists of retrieved articles and review articles in the field to identify additional publications.